Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-02-24 @ 2:06 PM
Study NCT ID:
NCT05219435
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-24
First Post:
2022-01-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SOGUG-2021-IEC(VEJ)-4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |